Flores RJ, Aguilar RF

Language: Spanish
References: 30
Page: 139-151
PDF size: 237.41 Kb.

ABSTRACT

The treatment of the diabetes mellitus is based on correcting the symptoms and preventing or to delay the apparition of the complications. It is required to identify in a early way that is possible, and opportune the disease and type of diabetes. There are three fundamentally type’s diabetes type 1 or infantile diabetes, the type 2 diabetes or the adult and the gestational diabetes. The prevention of the complications requires of the diagnostic early of the disease, combined to a new condition that it involves in his personal life of the patient and its family, the diet, the exercise and the daily and strict precise metabolic control. The gestational diabetes are exanimate with special emphasis in treatment of mother and new born. The therapeutic resources plus the changes of the life style and accepting the disease are the more important arms to avoid the complications in the long term.

REFERENCES

1. De los Ríos CJL, Sánchez-Sosa JJ, Barrios SP, Guerrero-Sustaita V. Calidad de vida en pacientes con DM. Rev Med IMSS 2004; 42(2): 109-116.

2. Lifshitz GA, Arréola E, Castro MMG y cols. A propósito de la diabetes en México. Rev Med IMSSS 1996; 34: 343-4.

3. Rubin RJ. Health care expenditures for people with diabetes mellitus. J Clin Endocrinol and Metabol 1994; 78: 809 A-809 E.

4. Libertad-Martín a Graua. La investigación de la adherencia terapéutica como un problema de psicología de la salud. Psicología y Salud 2004; 14(1): 89-99.

5. Ruiz RM, Escolar-Pujolar A, Mayoral-Sánchez E, Corral-San LF, Fernández-Fernández I. Mellitus diabetes in Spain: death rates, prevalence, impact, cost and inequalities. Gac Sanit 2006; 20(Suppl 1): 15-24.

6. Cholula HRJ. Education for a patient with gestational diabetes based on applied seven behaviors. Diabetes Hoy 2008; 9(6): 2150-3.

7. American Diabetes Association. Clinical Practice Recommendations 2004. Diabetes Care 2004; 27(Suppl 1): s1-150.

8. The diabetes control and complications trials research group the effect of intensive diabetes therapy on the development and progression of neuropathy. Ann intern med 1995; 122: 561-68.

9. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-depedent diabetes mellitus. New England Journal of Medicine; 329: 977-86.

10. UK-Prospective Diabetes study (UKPDS)-group (1998) Intensive blood-glucose control with sulfonylureas or insulin compared to conventional treatment and risk of complications in patients with type II diabetes (UKPDS 33). Lancet, 352; 837-853.

11. Roura-Olmeda P, Mata-Cases M, Cano-Pérez JF. Nuevas perspectivas en el tratamiento de la diabetes mellitus. Aten Primaria 2005; 35:229-32.

12. The Expert Committee on the Diagnosis and Classification of diabetes Mellitus: Follow-up reports the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-7

13. Robles VC. Fisiopatología de la diabetes tipo 1 o dependientes de insulina. En: Gómez PFJ. Avances en Diabetes. Tomo II. 1ra. ED. Corporativo Intermédica, S. A de C.V México. 1999, pp. 69-82.

14. Pérez PE. Etiopatogénesis de la diabetes tipo 1. En: Chavarría BC. Temas de Pediatría. Endocrinología 1ra ED. México MacGraw-Hill. 1998: 125-34.

15. Skilers JS. Marks JB. Immune intervention in type 1 diabetes. Diab Rev 1993; 1: 15-42.

16. Aguilar-Salinas CA, Rull JA, García E, et al. Consejo Mexicano para la Prevención de las Complicaciones Crónicas de la diabetes tipo 2. Avalado por la Sociedad Mexicana de Nutrición y endocrinología, Asociación de Medicina Interna de México y la Sociedad de Nutriología. Revista de Investigación Clínica 2000; 52: 325-63.

17. The California Healthcare Foundation/American Geriatric Society on improving care for elders with diabetes. Guidelines for improving the care of the older person with diabetes mellitus. Am J. Geriatric Soc 2003; 51: S265-80.

18. American Diabetes Assoc. Standards of medical care of patients with diabetes mellitus. Diabetes Care 2004; 22 (sup 1): s15-s35

19. American Diabetes Associative. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008; 31 (Suppl 1): s55-s60

20. Salcedo RAL, García de Alba-García JE, Fraire TMJ, López-Coutino B. Género y control de diabetes 2 en pacientes del primer nivel de atención. Rev Med Inst Mex Seguro Soc 2008; 46 (1): 73-81

21. Davidson MB. How do we diagnosis diabetes and measure blood glucose control? View 11 (diagnosing) a clinical bases for the diagnosis of diabetes. Diabetes spectrum 2001; 14: 67-70.

22. American Diabetes Assoc. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2004; 22 (Suppl 1): S15-S35.

23. American Diabetes Assoc. Screening for type 2 diabetes. Diabetes Care 2004; 22 (Suppl 1): S11-S14.

24. Perichart PO et al. Fisiopatología y atención nutricia de pacientes con diabetes gestacional. Ginecol Obstet Mex 2006; 74:218-23

25. González M, Jesús y González B, Eduardo. Diabetes y gestación. Obstetricia. 5ª Edición. Masson. España. 2006, 513-23.

26. Vega M, E. El diagnóstico de diabetes mellitus gestacional. Diabetes hoy para el médico y profesional de la salud. 2005; VI (5): 1518-19.

27. Setji L, Tracy et al. Gestational diabetes Mellitus. Clinical diabetes. 2005; 23(1):17-24.

28. Hadderson M, et al. Gestational diabetes mellitus and lesser degree of pregnancy hypoglycemia; Association of increase of spontaneous preterm birth. Obstetric & Gynecology 2003; 102: 852-6.

29. Kim C, Newton K, Knopp R. Gestational Diabetes and the incidence of type 2 Diabetes: a Systemic review. Diabetes Care 2002; 25: 1862-8.

30. U.S. Preventive Services Task Force. Screening for Gestational Diabetes mellitus. Recommendations and rationale. Obstetric & Gynecology 2003; 101(2): 393-5.